Related to Intellikine Earns $4M from Infinity on Start of Phase I Trials with PI3K Delta and Gamma

• 
• Sequencing Assays
• Roche
• GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
• 
• Tumor Marker Control
• Randox Laboratories
• The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
• 
• Knockout Cell Lines for Cancer Research
• Cellectis bioresearch
• The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
• 
• Transfection Reagent
• Mirus Bio
• TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
• 
• DNA Reference Standard
• Horizon Discovery
• The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds